Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States, Canada and Mexico.

2 Sep 2010

BRINAVESS IV granted marketing approval in EU for conversion of recent onset AF to sinus rhythm

MSD and Cardiome Pharma Corp. today announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.

2 Sep 2010

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.

2 Sep 2010

Focused health actions may promote optimal food consumption behaviour, intense physical activity pattern

The University of Athens Medical School has conducted a comprehensive study to evaluate the relationship between diet quality, levels of physical activity and key lifestyle characteristics amongst a group of 12-17 year old schoolchildren. The objective was to determine the most appropriate health actions to reduce the risks of long-term cardiovascular disease. The study concludes that almost half of Greek schoolchildren have a low quality diet, while just 6 percent adhere to the traditional Mediterranean diet along with high levels of physical activity.

2 Sep 2010

Illinois profs receive grant to work with kidney dialysis patients

University of Illinois scientists will learn whether protein supplements and cycling during treatments can help dialysis patients fight cardiovascular disease and retain physical function, thanks to a $2.1 million grant from the National Institutes of Health (NIH).

2 Sep 2010

Moderate consumption of coffee benefits aortic distensibility in hypertensive elderly individuals

A detailed study conducted by a team from the University of Athens on the Aegean island of Ikaria has demonstrated that moderate consumption of coffee by hypertensive elderly individuals can lead to improvements in aortic distensibility. Distensibility is a measure of the elasticity of arteries, and low levels have long been recognised as an indicator of atherosclerosis and a reliable predictor of future cardiovascular events.

2 Sep 2010

DASH eating plan reduces heart disease risk in African Americans: Study

A new study suggests yet another reason for Americans to abandon their current fatty diets in favor of one rich in fruits and vegetables and low in saturated fat. Choosing these healthier options appears to significantly reduce the long-term risk of heart disease in patients with mildly elevated blood pressure, particularly African Americans.

2 Sep 2010

Incidence of acute myocardial infarction increases among young Italian women: Study

The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation, a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. The results were published in Aging Clinical Experimental Research.

31 Aug 2010

Study on conflict between capacity to pay and need for health care

Cardiovascular disease (CVD) in all its forms is the biggest cause of death across Europe. Although there is little doubt that better focus on prevention can lessen its impact, we are left with a series of fundamental questions to what extent can the impact be reduced, and at what cost. And are the health benefits of prevention worth the investment. The EUROASPIRE III health economics study aims to find out.

31 Aug 2010

Nutritional recommendations for management of sarcopenia published

Nutritional recommendations for the management of sarcopenia -- also described as age-related muscle and functional loss -- were published this past week in the clinical publication, Journal of American Medical Directors Association.

31 Aug 2010

ECG-based screening for young footballers at risk of heart disease needs to be reviewed: Study

The screening process for young footballers at risk of heart disease needs to be re-evaluated. That is the conclusion of a recent study, which has shown that the common criteria used for assessment does not take into account the type and intensity of the exercise performed. The single most common cause of sudden death in competitive footballers is hypertrophic cardiomyopathy - a disease that thickens the heart muscle without any obvious cause.

31 Aug 2010

International Symposium to explore Hybrid approach for congenital heart disease

Interventional cardiologists and cardiothoracic surgeons throughout the United States and the world, who treat patients with congenital heart disease, will gather at the Hilton Columbus at Easton Town Center August 31-September 2, 2010 for the International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).

31 Aug 2010

Data monitoring committee recommends early termination following impressive results of AVERROES study

The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early termination of this study. The decision came after repeated review and careful consideration of all efficacy and safety data.

31 Aug 2010

Increasing trend seen in hospital admissions due to atrial fibrillation

A growing epidemic of the world's most common heart rhythm disorder is resulting in an alarming number of hospital admissions in Australia, according to cardiology researchers.

31 Aug 2010

Peripheral arterial disease increases cardiovascular disease risk: Study

Most patients don't suspect a thing, and yet they are seriously ill: hardening of the arteries - peripheral arterial disease PAD - doubles the risk of premature death and serious cardiovascular events such as heart attack and stroke.

31 Aug 2010

Hospital admissions in Australia due to atrial fibrillation triples

A growing epidemic of the world's most common heart rhythm disorder is resulting in an alarming number of hospital admissions in Australia, according to cardiology researchers.

31 Aug 2010

Amsterdam Molecular first half 2010 net loss in line with last year

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the first half year of 2010.

31 Aug 2010

Patients with atherothrombosis are at increased risk of ischemic events: Study

Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.

30 Aug 2010

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

Genzyme Corp. today confirmed that it has received an unsolicited, non-binding proposal from Sanofi-Aventis to acquire all the outstanding shares of Genzyme for $69 per share in cash. The Genzyme board of directors met last night, unanimously affirmed its previous rejection of Sanofi's proposal, and instructed the company to send Sanofi the following response letter:

30 Aug 2010

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

MedCath Corporation announced today it has entered into a definitive agreement to sell its subsidiary which is the indirect owner of a one-third ownership interest and management rights in Avera Heart Hospital of South Dakota to Avera McKennan. The transaction is expected to close in 45 to 90 days, subject to certain closing conditions.

30 Aug 2010

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Orexigen and Takeda partner to develop, commercialize Contrave in US, Canada and Mexico

BRINAVESS IV granted marketing approval in EU for conversion of recent onset AF to sinus rhythm

Mipomersen Phase 3 trial in heFH meets primary, secondary and tertiary endpoints

Focused health actions may promote optimal food consumption behaviour, intense physical activity pattern

Illinois profs receive grant to work with kidney dialysis patients

Moderate consumption of coffee benefits aortic distensibility in hypertensive elderly individuals

DASH eating plan reduces heart disease risk in African Americans: Study

Incidence of acute myocardial infarction increases among young Italian women: Study

Study on conflict between capacity to pay and need for health care

Nutritional recommendations for management of sarcopenia published

ECG-based screening for young footballers at risk of heart disease needs to be reviewed: Study

International Symposium to explore Hybrid approach for congenital heart disease

Data monitoring committee recommends early termination following impressive results of AVERROES study

Increasing trend seen in hospital admissions due to atrial fibrillation

Peripheral arterial disease increases cardiovascular disease risk: Study

Hospital admissions in Australia due to atrial fibrillation triples

Amsterdam Molecular first half 2010 net loss in line with last year

Patients with atherothrombosis are at increased risk of ischemic events: Study

Genzyme responds to Sanofi-Aventis' unsolicited acquisition proposal

MedCath to sell interest in Avera Heart Hospital of South Dakota to Avera McKennan

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in